You are here

Few Women at High Risk for Hereditary Breast and Ovarian Cancer Receive Genetic Counseling

Only 10% report counseling or testing in campus study

Mutations in the BRCA1 and BRCA2 genes account for nearly 25% of hereditary breast cancers and most hereditary ovarian cancers, and yet a study by cancer prevention and control researchers at Virginia Commonwealth University (VCU) suggests that only a small number of women who qualify for BRCA genetic counseling actually receive those services.

In addition, they found that a significant proportion of women with a family history of breast and ovarian cancer underestimate their own risk.

The study, published in the April edition of the Journal of Community Genetics, collected data from 486 women over the course of 2 years. Of these women, 22 met the criteria to be referred for BRCA counseling. However, only one of the women reported receiving genetic counseling, and only one reported prior genetic testing.

Moreover, although the perceived risk of developing breast and ovarian cancer was higher among high-risk women, 27% of these women felt that their risk was “low,” and 32% felt that their risk was “lower than average.”

“Despite recommendations from the United States Preventive Services Task Force that primary care physicians screen for hereditary cancer risk, it seems that too few women who meet the eligibility criteria are actually following through with BRCA counseling services,” said lead investigator John Quillin, PhD, MPH. “Unfortunately, this means that a significant number of women who are at high-risk for developing breast and ovarian cancer may not be taking advantage of preventive measures that could ultimately save their lives.”

The researchers analyzed data from a pilot study called Kin Fact (Keeping INformation About FAmily Cancer Tune-Up), which was conducted at the VCU Women’s Health Clinic. Kin Fact works by having a clinical research associate intervene during a woman’s annual gynecology appointment to discuss the patient’s genetic cancer risks.

Participants were asked to complete a survey that asked questions about their knowledge of genetic counseling and their perceived cancer risk. After the survey was completed, the study’s recruiters obtained information about the patient’s hereditary cancer risks by noting all breast and ovarian cancers among first-and second-degree relatives.

The researchers’ goals were to assess the number of women eligible for BRCA counseling in a primary care setting; to explore associations between high-risk status and characteristics such as age, race, and genetic literacy; and to determine whether high-risk patients received genetic counseling and/or testing.

“We need to examine whether patients are fully aware of their family history, and if there are ways to optimize family history collection in clinical settings,” Quillin said. “This will help determine if educational interventions are needed for providers, patients, or both.”

Source: EurekAlert; May 8, 2014.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks